BTI Liquid 5% AS for Government Hospital Mosquito Control Procurement in India Covering Biological Mosquito Larvicide Supply, Hospital Campus Vector Management, Public Health Tenders, Technical Specifications

BTI Liquid 5% AS for Government Hospital Mosquito Larvae Control Programmes

Bacillus thuringiensis subsp. israelensis (BTI) Liquid 5% AS is a biological mosquito larvicide formulated as an aqueous suspension for controlling susceptible mosquito larvae in approved aquatic breeding environments. Government hospitals, district hospitals, medical college hospitals, public health institutions and hospital facility management departments may consider registered BTI formulations as part of integrated mosquito management programmes. Hospital campuses may contain mosquito breeding opportunities in poorly maintained drainage systems, stagnant water collections, construction areas, open water storage structures and other locations where water accumulates. Effective mosquito management requires regular inspection of these areas, elimination of avoidable breeding sites and appropriate larval control measures. BTI Liquid 5% AS may be considered for suitable habitats where its registration and approved label permit application.

Hospital mosquito control programmes should be coordinated with infection prevention teams, environmental health personnel, sanitation departments and authorized pest management contractors. Mosquito larvae management can complement drainage maintenance, water storage protection, waste management and routine environmental surveillance. Public health facilities should prioritize safe operational practices because patients, healthcare workers, visitors and maintenance personnel may be present throughout the treatment period. Product selection should consider the target mosquito species, habitat characteristics, approved application instructions and operational requirements. BTI Liquid 5% AS is intended for larval control rather than direct adult mosquito control, and it should not be represented as a substitute for all other vector management measures.

Government Hospital Procurement Procedures and Institutional Tender Requirements

Government hospitals may procure BTI Liquid 5% AS through authorized institutional purchasing procedures, state medical procurement agencies, health department procurement systems, the Government e-Marketplace (GeM) or other government tender platforms where applicable. Purchasing requirements may be issued by hospital administration departments, medical superintendents, procurement officers, public works units or authorized facility management agencies. Tender descriptions may include biological mosquito larvicide, mosquito larvae control material, public health vector control products or BTI Liquid 5% AS. Manufacturers and suppliers should review the actual procurement documents before submitting quotations because the required formulation, quantity, packaging, technical specifications and delivery conditions may vary between institutions.

Government hospital tender participation may require supplier registration, manufacturing licences, product registration certificates, approved labels, Technical Data Sheets, Certificates of Analysis and manufacturer authorization documents where specified. Institutional buyers should verify whether a tender is for direct material purchasing or for a broader mosquito control service contract that includes labour, equipment, inspection and application responsibilities. Suppliers offering BTI Liquid 5% AS should ensure that their product matches the stated formulation and approved uses. Financial quotations should follow the prescribed unit of measurement and include applicable taxes, packaging and delivery charges as required. Purchasing authorities should evaluate technical compliance before comparing eligible commercial offers according to the applicable procurement rules.

Technical Specifications, Product Registration and Hospital Safety Requirements

BTI Liquid 5% AS technical specifications should identify the biological organism, aqueous suspension formulation, declared concentration and relevant registered product characteristics. Quality documentation may include biological potency, microbial quality, batch identification, formulation stability and other parameters appropriate to the registered product. The declared 5% concentration, viable microbial count and larvicidal potency are different measurements and should not be treated as interchangeable. Government hospital procurement officers should request technical documents that support verification of the product being supplied. A batch-specific Certificate of Analysis may help establish compliance with applicable quality requirements, while a Technical Data Sheet provides information about formulation characteristics, handling, storage and other relevant product details.

Hospital safety considerations should be incorporated into product acceptance and field application planning. BTI Liquid 5% AS should be handled and applied according to its approved label, applicable public health guidance and institutional safety procedures. Application should be restricted to approved sites and carried out by appropriately trained personnel. Special care is required around patient care areas, drinking water systems, medical equipment, food preparation facilities and other sensitive locations. A product should not be applied to a water system merely because mosquito larvae are present; its registered uses and any applicable site-specific restrictions must first be verified. Receiving departments should inspect packaging integrity, manufacturing dates, expiry dates, batch numbers and remaining shelf life before accepting supplies.

Institutional Bulk Purchasing, Hospital Campus Distribution and Supplier Selection

Government hospitals and public medical institutions may purchase BTI Liquid 5% AS in quantities appropriate to their campus size, surveillance findings and mosquito management schedules. Larger medical college campuses, multi-building hospital complexes and public health institutions may require coordinated purchasing and distribution arrangements. Procurement officers should estimate quantities using approved application rates, the characteristics of relevant breeding habitats and realistic treatment schedules. Institutional bulk purchasing may provide logistical advantages, but excessive stock should be avoided where shelf-life limitations or storage conditions could affect product quality. Hospital stores should maintain suitable inventory records and follow the approved storage instructions.

Supplier selection should consider valid product documentation, formulation compliance, manufacturing or distribution capability, delivery reliability and total procurement cost. Government hospitals may require deliveries to central medical stores, facility maintenance departments or designated public health units. Manufacturers and authorized suppliers should provide clearly labelled packaging, appropriate batch records and applicable dispatch documentation. Where mosquito control services are outsourced, the hospital should clarify whether the contractor or institution is responsible for purchasing, storage and application. Bactostore India welcomes enquiries from government hospitals, district hospitals, medical colleges, healthcare institutions and authorized mosquito control contractors regarding BTI Liquid 5% AS technical information, institutional procurement documentation and potential bulk supply arrangements.